Skip to main content

Table 1 Baseline characteristics in unmatched and matched cohorts

From: Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?

 

Unmatched

PSMa

non-AC n = 138

AC n = 288

p

SD1

non-AC n = 111

AC n = 111

SD2

Age, year

67 (57–72)

67.5 (56.25–75.00)

0.500

0.036

67 (57–71)

67 (56–73)

-0.033

BMI, kg/m2

22.5 (20.5–25.4)

24.03 (21.4–26.1)

0.012

0.228

22.5 (20.5–25.6)

23.5 (20.0–25.4)

-0.052

Male, n (%)

84 (60.9)

135 (46.9)

0.007

-0.284

64 (57.7)

60 (54.1)

-0.073

HTN, n (%)

68 (49.3)

115 (39.9)

0.068

-0.190

49 (44.1)

52 (46.8)

0.054

DM, n (%)

34 (24.6)

41 (14.2)

0.008

-0.265

20 (18.0)

19 (17.1)

-0.024

RI, n (%)

22 (15.9)

28 (9.7)

0.062

-0.186

17 (15.3)

15 (13.5)

-0.051

HI, n (%)

17 (12.3)

24 (8.3)

0.192

-0.132

12 (10.8)

13 (11.7)

0.028

Bedridden (≥ 3 days), n (%)

94 (68.1)

171 (59.4)

0.082

-0.182

70 (63.1)

70 (63.1)

0.000

ICU, n (%)

65 (47.1)

100 (34.7)

0.014

-0.254

46 (41.4)

49 (44.1)

0.055

Sepsis, n (%)

5 (3.6)

9 (3.1)

0.787

-0.028

4 (3.6)

7 (6.3)

0.125

AMI, n (%)

3 (2.2)

8 (2.8)

0.713

0.038

3 (2.7)

6 (5.4)

0.137

CHF, n (%)

7 (5.1)

13 (4.5)

0.799

-0.028

5 (4.5)

6 (5.4)

0.042

Stroke, n (%)

45 (32.6)

50 (17.4)

0.000

-0.357

27 (24.3)

22 (19.8)

-0.109

Paraplegia, n (%)

2 (1.4)

7 (2.4)

0.724

0.073

2 (1.8)

3 (2.7)

0.061

Malignancy history, n (%)

21 (15.2)

45 (15.6)

0.967

0.011

19 (17.1)

20 (18.0)

0.024

Chemo-radiotherapy, n (%)

7 (5.1)

16 (5.6)

0.836

0.022

6 (5.4)

5 (4.5)

-0.042

VTE history, n (%)

0 (0.0)

0 (0.0)

-

0.000

0 (0.0)

0 (0.0)

0.000

Pregnancy, n (%)

0 (0.0)

1 (0.3)

1.000

0.078

0 (0.0)

0 (0.0)

0.000

Surgery, n (%)

56 (40.6)

192 (66.7)

0.000

0.542

53 (47.7)

53 (47.7)

0.000

WBC, 109/L

8.70 (6.52–11.01)

7.46 (5.75–10.46)

0.036

-0.112

8.64 (6.37–10.79)

7.94 (5.79–10.80)

-0.041

HG, g/L

109 (95–126)

115 (99–128)

0.130

0.127

109 (96–124)

114 (96–126)

0.012

PLT, 109/L

200 (146–265)

189 (148–263)

0.983

0.012

201 (146–270)

191 (151–268)

0.026

CREA, μmol/L

65.8 (55.0–79.8)

68.6 (55.4–84.9)

0.465

0.001

66.0 (54.6–78.5)

69.7 (55.6–87.3)

0.113

D-dimer, mg/L

0.99 (0.54–2.99)

1.04 (0.48–2.84)

0.682

0.015

1.00 (0.54–2.99)

1.19 (0.57–2.87)

0.111

  1. BMI Body mass index, AC Anticoagulation, SD Standardized difference, HTN Hypertension, DM Diabetes mellitus, RI Renal insufficiency, HI Hepatic insufficiency, ICU Intensive care unit, AMI Acute myocardial infarction, CHF Congestive heart failure, VTE Venous thromboembolism, WBC White blood cell, HG Hemoglobin, PLT Platelet, CREA Creatine, PSM Propensity score matching
  2. aPropensity score of each patient was calculated by binary logistic regression model, treatment type (anticoagulation or not) was considered as dependent variable, and the independent variables contained age, male, BMI, HTN, DM, RI, HI, bedridden (≥ 3 days), ICU, stroke, malignancy history, surgery, WBC, and HG